Cancer Clinical Investigation

Search results

• FDA approves new CAR T-cell treatment for multiple myeloma

  Sundar Jagannath

  1/03/22

  1 item of Media coverage

  Press/Media

• FDA approves Carvykti as second CAR T-cell therapy for advanced multiple myeloma

  Sundar Jagannath

  1/03/22

  1 item of Media coverage

  Press/Media

• Janssen's First Cell Therapy Approved by FDA for Patients with Multiple Myeloma

  Sundar Jagannath

  1/03/22

  2 items of Media coverage

  Press/Media

• USFDA accelerates approval of CTI BioPharma's pacritinib

  John Mascarenhas

  1/03/22

  1 item of Media coverage

  Press/Media

• CTI BioPharma Announces FDA Accelerated Approval Of VONJO™ (pacritinib) For The Treatment Of Adult Patients With Myelofibrosis And Thrombocytopenia

  John Mascarenhas

  28/02/22 → 1/03/22

  76 items of Media coverage

  Press/Media

• 19:19 EST CTI BioPharma announces FDA accelerated approval of VONJO

  John Mascarenhas

  1/03/22

  1 item of Media coverage

  Press/Media

• FDA Approves Pacritinib for Myelofibrosis and Thrombocytopenia

  John Mascarenhas

  1/03/22

  3 items of Media coverage

  Press/Media

• U.S. FDA Approves CARVYKTI (ciltacabtagene autoleucel), Janssen's First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma'

  Sundar Jagannath

  28/02/22

  1 item of Media coverage

  Press/Media

• CTI BioPharma Announces FDA Accelerated Approval of VONJO (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia'

  John Mascarenhas

  28/02/22

  1 item of Media coverage

  Press/Media

• Study of Cemiplimab Use in Hepatocellular Carcinoma Meets Primary End Points

  Thomas Marron

  26/02/22

  1 item of Media coverage

  Press/Media

• University of North Carolina at Chapel Hill Assigned Patent for Heterochromatin Gene Repression Inhibitors

  Jian Jin

  24/02/22

  1 item of Media coverage

  Press/Media

• U.S. Patents Awarded to Inventors in Utah (Feb. 24)

  Jian Jin

  24/02/22

  1 item of Media coverage

  Press/Media

• U.S. Patents Awarded to Inventors in North Carolina (Feb. 24)

  Jian Jin

  24/02/22

  2 items of Media coverage

  Press/Media

• US Patent Issued to The University of North Carolina at Chapel Hill on Feb. 22 for "Heterochromatin gene repression inhibitors" (North Carolina, New York, Utah Inventors)

  Jian Jin

  22/02/22

  1 item of Media coverage

  Press/Media

• Checkpoint Inhibitor Changes Take Hold: Approval Standards Stir Debate

  Matthew Galsky

  16/02/22

  1 item of Media coverage

  Press/Media

• The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study

  John Mascarenhas

  14/02/22

  1 item of Media coverage

  Press/Media

• Karyn Goodman, MD @KarynAGoodman @IcahnMountSinai # ASCOGI22 #SKYSCRAPER07 #ESCC Phase III SKYSCRAPER-07 Study

  Karyn Goodman

  7/02/22

  2 items of Media coverage

  Press/Media

• Pre-Op Treatment May Be Advance Against Deadly Liver Cancers.

  Thomas Marron

  28/01/22 → 3/02/22

  2 items of Media coverage

  Press/Media

• Preoperative treatment may advance for deadly liver cancer

  Thomas Marron

  30/01/22

  1 item of Media coverage

  Press/Media

• Immunotherapy before surgery killed off liver tumors in one-third of patients, study finds

  Thomas Marron

  29/01/22

  1 item of Media coverage

  Press/Media

• Immunotherapy before surgery killed off liver tumors in one-third of patients, study finds

  Thomas Marron

  28/01/22

  1 item of Media coverage

  Press/Media

• Neoadjuvant cemiplimab promising for resectable liver cancer

  Thomas Marron

  28/01/22

  1 item of Media coverage

  Press/Media

• Pre-Op Treatment May Be Advance Against Deadly Liver Cancers

  Thomas Marron

  28/01/22

  3 items of Media coverage

  Press/Media

• Pre-Op Treatment May Be Advance Against Deadly Liver Cancers

  Thomas Marron

  28/01/22

  165 items of Media coverage

  Press/Media

• Immunotherapy before surgery killed off liver tumors in one-third of patients, study finds

  Thomas Marron

  27/01/22

  2 items of Media coverage

  Press/Media